Wegovy, a separate Novo Nordisk product that also contains semaglutide, is FDA-approved for specified weight-management indications - the two are not interchangeable, and only one is approved for weight management
Given that tirzepatide has not been studied in individuals with non-proliferative retinopathy requiring acute therapy, proliferative retinopathy or diabetic macular oedema, caution must be exercised in these groups
ALSO READ: Benefits of Semaglutide Injections Oral Vs Injectable Semaglutide What You Need to Know Before Starting Treatment
Realistic expectations : Understanding that these medications work best as part of a comprehensive approach to health, not as a quick fix
Choose the option that best fits how youd like to send scripts or connect with us
I 2 = 96.4%, p 30 kg/m 2 ) [WMD = 1.28